To further confirm these results, we also investigated the expression of FOXC1 and FOXCUT in four hepatocellular cancer cell lines and five breast cancer cell lines, and found that both FOXC1 and FOXCUT expressions were higher in these cancer cells than in normal cells. This evidence concerns the gene FOXC1 and cancer.